UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Molecular cancer therapeutics, 2017-11, Vol.16 (11), p.2598-2608

2017

Volltextzugriff (PDF)

Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients

Clinical cancer research, 2016-11, Vol.22 (22), p.5497-5505

2016

Volltextzugriff (PDF)

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

Clinical cancer research, 2020-05, Vol.26 (10), p.2290-2296

2020

Volltextzugriff (PDF)

Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy

Clinical cancer research, 2017-10, Vol.23 (19), p.5729-5736

2017

Volltextzugriff (PDF)

Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysis

JAMA oncology, 2019-04, Vol.5 (4), p.529

2019

Volltextzugriff (PDF)

Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer

JAMA oncology, 2020-12, Vol.6 (12), p.1952

2020

Volltextzugriff (PDF)

Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial

JNCI : Journal of the National Cancer Institute, 2024-05, Vol.116 (5), p.673-680

2024

Volltextzugriff (PDF)

Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma

Clinical cancer research, 2017-09, Vol.23 (17), p.5101-5111

2017

Volltextzugriff (PDF)

Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.1901-1911

2019

Volltextzugriff (PDF)

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e002990

2021

Volltextzugriff (PDF)

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

BMC cancer, 2020-05, Vol.20 (1), p.383-13, Article 383

2020

Volltextzugriff (PDF)

Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials

Cancer, 2022-02, Vol.128 (4), p.770-777

2022

Volltextzugriff (PDF)

Landscape of Immune-Related Pneumonitis in Cancer Patients with Asthma Being Treated with Immune Checkpoint Blockade

Oncology, 2020-02, Vol.98 (2), p.123-130

2020

Volltextzugriff (PDF)

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

Cancer Immunology, Immunotherapy, 2020-07, Vol.69 (7), p.1177-1187

2020

Volltextzugriff (PDF)

In Vitro Cytotoxicity and Aromatase Inhibitory Activity of Flavonoids: Synthesis, Molecular Docking and In silico ADME Prediction

Anti-cancer agents in medicinal chemistry, 2022-04, Vol.22 (7), p.1370-1385

2022

Volltextzugriff (PDF)

Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions

Scientific reports, 2020-08, Vol.10 (1), p.13203-13203, Article 13203

2020

Volltextzugriff (PDF)

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia

Clinical cancer research, 2024-01, Vol.30 (1), p.33-38

2024

Volltextzugriff (PDF)

A computational model of lysosome-ER Ca2+ microdomains

Journal of cell science, 2014-07, Vol.127 (Pt 13), p.2934-2943

2014

Volltextzugriff (PDF)

Antiurolithiatic and antioxidant activity of Hordeum vulgare seeds on ethylene glycol-induced urolithiasis in rats

Indian journal of pharmacology, 2012-11, Vol.44 (6), p.672-677

2012

Volltextzugriff (PDF)

Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.2235-2242

2023

Volltextzugriff (PDF)

Telomerase reverse transcriptase promoter alterations across cancer types as detected by next‐generation sequencing: A clinical and molecular analysis of 423 patients

Cancer, 2018-03, Vol.124 (6), p.1288-1296

2018

Volltextzugriff (PDF)

Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2024-02, Vol.12 (2), p.e007340

2024

Volltextzugriff (PDF)

Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria

Scientific reports, 2016-04, Vol.6 (1), p.24557-24557, Article 24557

2016

Volltextzugriff (PDF)

Top Ten Tips for Palliative Care Clinicians Caring for Cancer Patients Receiving Immunotherapies

Journal of palliative medicine, 2018-05, Vol.21 (5), p.694-699

2018

Volltextzugriff (PDF)

Clinical Proteomics and Cytokine Profiling for Dengue Fever Disease Severity Biomarkers

Omics (Larchmont, N.Y.), 2017-11, Vol.21 (11), p.665-677

2017

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(71)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy

Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysis

Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer

Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial

Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma

Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials

Landscape of Immune-Related Pneumonitis in Cancer Patients with Asthma Being Treated with Immune Checkpoint Blockade

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

In Vitro Cytotoxicity and Aromatase Inhibitory Activity of Flavonoids: Synthesis, Molecular Docking and In silico ADME Prediction

Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia

A computational model of lysosome-ER Ca2+ microdomains

Antiurolithiatic and antioxidant activity of Hordeum vulgare seeds on ethylene glycol-induced urolithiasis in rats

Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

Telomerase reverse transcriptase promoter alterations across cancer types as detected by next‐generation sequencing: A clinical and molecular analysis of 423 patients

Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors

Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria

Top Ten Tips for Palliative Care Clinicians Caring for Cancer Patients Receiving Immunotherapies

Clinical Proteomics and Cytokine Profiling for Dengue Fever Disease Severity Biomarkers

Aktive Filter

Suchergebnisse filtern